Search results for "ovulation"

showing 10 items of 127 documents

Antral Follicle Priming Before Intracytoplasmic Sperm Injection in Previously Diagnosed Low Responders: A Randomized Controlled Trial (FOLLPRIM).

2015

A low response to controlled ovarian hyperstimulation implies a reduced number of embryos and impaired pregnancy rate. Follicular priming with steroids before controlled ovarian hyperstimulation has been suggested to improve the subsequent ovarian response.The purpose of this study was to determine the best follicular priming protocol in low responders and to investigate the intrafollicular mechanisms triggered by steroid hormone priming.This was a single-center, randomized, parallel, open-label, controlled trial, in two phases.The setting was a university-based in vitro fertilization unit.Potential low responders (n = 99) underwent a first intracytoplasmic sperm injection cycle. Confirmed …

AdultMaleendocrine systemmedicine.medical_specialtyPregnancy RateEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryPriming (immunology)Oocyte RetrievalControlled ovarian hyperstimulationLuteal PhaseAdministration CutaneousBiochemistryIntracytoplasmic sperm injectionlaw.inventionAndrologyEndocrinologyRandomized controlled trialOvarian FollicleOvulation InductionlawPregnancyInternal medicineFollicular phasemedicineHumansTestosteroneSperm Injections IntracytoplasmicOvarian reserveOvarian ReserveIn vitro fertilisationEstradiolbusiness.industryBiochemistry (medical)Antral follicleEndocrinologyFemalebusinessInfertility FemaleThe Journal of clinical endocrinology and metabolism
researchProduct

Clinical success of intrauterine insemination cycles is affected by the sperm preparation time.

2013

Objective To determine the impact of the time interval from the end of sperm preparation (TSP) to intrauterine insemination (IUI) on the outcome. Design Prospective multicentre cohort study. Setting Seven French centers (assisted reproduction group in northeastern France, four academic centers, and three clinics). Patient(s) Eight hundred sixty-two IUI cycles (709 patients) managed by gonadotropins were studied. Intervention(s) Cycles were stimulated by either FSH or hMG, and hCG was administrated when the leading follicle diameter measured >15 mm. IUIs were performed ∼36 hours after ovulation triggering. Main Outcome Measure(s) Generalized linear mixed models for binary outcomes were used …

AdultMaleendocrine systemmedicine.medical_specialtyTime FactorsPregnancy Ratemedia_common.quotation_subjectReproductive medicinelaw.inventionSpecimen HandlingSemen qualityRandomized controlled trialOvulation InductionlawPregnancyOdds RatioMedicineHumansProspective StudiesOvulationmedia_commonUnexplained infertilityInsemination Artificial HomologousGynecologyPregnancybusiness.industryAge FactorsObstetrics and GynecologyFertility Agents Femalemedicine.diseaseSpermatozoaTissue DonorsSemen AnalysisPregnancy rateFertilityTreatment OutcomeReproductive MedicineInfertilityMultivariate AnalysisLinear ModelsFemaleFrancebusinessCohort studyFertility and sterility
researchProduct

The amelioration of olfactory acuity upon sexual maturation might affect food preferences.

2009

Upon sexual maturation, olfactory acuity in women ameliorates and starts oscillating across the cycle. During ovulation, mean olfactory threshold is 30 times lower than during bleeding. Interestingly, menstruated women undergo maleodorant trimethylaminuria. We argued that olfactory amelioration during ovulation might concur to a mating strategy, whereas olfactory impairment during bleeding might protect women against self-refusal. Testosterone and its 17β-estradiol derivative might be responsible for the synchronization of these menstrual events. Furthermore, we posed the question whether olfactory detection amelioration upon sexual maturation might provoke a change in food preferences, for…

AdultMalemedicine.medical_specialtyAdolescentolfactory thresholdmedia_common.quotation_subjectlcsh:TX341-641ReviewBiologyAffect (psychology)menstrual cycleMenstruationFood PreferencesMethylaminesYoung AdultSex FactorsInternal medicinemedicineOlfactory thresholdSexual maturityHumansSexual MaturationMatingChildOvulationMenstrual cyclemedia_commonNutrition and DieteticsEstradiolTestosterone (patch)fish consumptionSmellEndocrinologyItalySeafoodChild PreschooltestosteronetrimethylamineFemalelcsh:Nutrition. Foods and food supplyFood ScienceNutrients
researchProduct

Monozygotic twinning after assisted reproductive technologies: a case report of asymmetric development and incidence during 19 years in an internatio…

2015

Objective To describe a case of monozygotic twinning with asymmetric development following a single fresh embryo transfer as part of an intracytoplasmic sperm injection (ICSI) treatment. Secondarily, to report the incidence of monozygotic twinning at the IVI (Instituto Valenciano de Infertilidad) clinics. Design Case report. Setting Private fertility centers. Patient(s) A 33-year-old woman with a 2-year history of primary infertility. Intervention(s) Controlled ovarian hyperstimulation and ICSI treatment with single-embryo transfer. Main Outcome Measure(s) Incidence of monozygotic twinning at the IVI clinics. Result(s) We report a twin pregnancy after a single-embryo transfer. Twins were di…

AdultMalemedicine.medical_specialtyDatabases FactualReproductive Techniques Assistedmedia_common.quotation_subjectmedicine.medical_treatmentFertilityReproductive technologyControlled ovarian hyperstimulationUltrasonography PrenatalIntracytoplasmic sperm injectionOvulation InductionPredictive Value of TestsPregnancySingle Embryo TransfermedicineHumansGenetic TestingSperm Injections IntracytoplasmicInfertility MaleTwin Pregnancymedia_commonGynecologyPregnancyIn vitro fertilisationTwinning Monozygoticbusiness.industryIncidence (epidemiology)Obstetrics and GynecologyTwins Monozygoticmedicine.diseaseFertilityTreatment OutcomeReproductive MedicinePregnancy TwinFemalebusinessLive BirthFertility and Sterility
researchProduct

Twins born after transplantation of ovarian cortical tissue and oocyte vitrification

2009

Objective To present a combination of ovarian tissue and oocyte cryopreservation as an effective strategy for achieving pregnancy in a breast cancer patient. Design Case report. Setting Tertiary care university-affiliated hospital, tissue bank, and infertility clinic. Patient(s) A 36-year-old patient diagnosed with atypical medullar breast cancer and negative for estrogen, P, and HER2 receptors underwent ovarian tissue cryopreservation before receiving chemotherapy and radiotherapy. Intervention(s) Laparoscopic ovarian cortex extraction, ovarian tissue cryopreservation, ovarian tissue thawing and transplantation, controlled ovarian stimulation (COS), oocyte retrieval, vitrification and IVF,…

AdultMalemedicine.medical_specialtyOvarian Cortexmedicine.medical_treatmentTwinsOocyte RetrievalBreast NeoplasmsGestational AgeFertilization in VitroBiologyCryopreservationEmbryo Culture TechniquesAndrologyOvulation InductionPregnancymedicineHumansOvarian tissue cryopreservationFertility preservationCryopreservationGynecologyOvaryInfant NewbornObstetrics and GynecologyOocyte cryopreservationEmbryo TransferEmbryo transferTransplantationFertilityTreatment OutcomeReproductive MedicineOocytesFemaleOvulation inductionFertility and Sterility
researchProduct

Female obesity impairs in vitro fertilization outcome without affecting embryo quality.

2008

Objective To compare embryo quality and reproductive outcome in our IVF program according to the women's body mass index (BMI). Design Retrospective study. Setting University-affiliated infertility clinic, between January 2001 and April 2007. Patient(s) Women undergoing a total of 6,500 IVF–intracytoplasmic sperm injection (ICSI) cycles. Intervention(s) Six thousand five hundred IVF-ICSI cycles were included and divided into four groups: lean ( 2 ; n=1,070; 16.5%); normal (20–24.9 kg/m 2 ; n=3,930; 60.5%); overweight (25–29.9 kg/m 2 ; n=1,081; 16.6%); and obese (≥30 kg/m 2 ; n=419; 6.4%). Main Outcome Measure(s) Comparison of embryo quality and reproductive outcome (implantation, pregnancy,…

AdultMalemedicine.medical_specialtyPregnancy Ratemedicine.medical_treatmentFertilization in VitroMiscarriageBody Mass IndexOvulation InductionThinnessPregnancymedicineHumansObesitySperm Injections IntracytoplasmicMetaphaseRetrospective StudiesGynecologyPregnancyIn vitro fertilisationObstetricsbusiness.industryBody WeightSmokingObstetrics and GynecologyOverweightmedicine.diseaseAbortion SpontaneousPregnancy rateTreatment OutcomeReproductive MedicineFertilizationembryonic structuresOocytesGestationFemalebusinessLive birthBody mass indexEmbryo qualityFertility and sterility
researchProduct

Day-3 embryo metabolomics in the spent culture media is altered in obese women undergoing in vitro fertilization

2015

Objective To determine whether the global metabolomic profile of the spent culture media (SCM) of day-3 embryos is different in obese and normoweight women undergoing in vitro fertilization (IVF). Design Prospective cohort analysis. Setting IVF clinic. Patient(s) Twenty-eight young, nonsmoking women with normoweight, nonsmoking male partners with mild/normal sperm factors undergoing a first IVF attempt for idiopathic infertility, tubal factor infertility, or failed ovulation induction: obese ovulatory women (n = 12); obese women with polycystic ovary syndrome (PCOS; n=4); normoweight ovulatory women (n = 12). Intervention(s) Fifty μl of SCM collected from two day-3 embryos of each cohort. M…

AdultMalemedicine.medical_specialtyProteomemedicine.medical_treatmentPhysiologyFertilization in VitroEmbryo Culture TechniquesHuman fertilizationInternal medicinemedicineHumansObesityProspective cohort studyIn vitro fertilisationbusiness.industryObstetrics and GynecologyEmbryoTubal factor infertilityEmbryo TransferEmbryo Mammalianmedicine.diseasePolycystic ovaryCulture MediaEndocrinologyGene Expression RegulationReproductive MedicineCohortMetabolomeFemaleOvulation inductionbusinessInfertility FemalePolycystic Ovary SyndromeFertility and Sterility
researchProduct

Ovarian stimulation does not influence the uterine immune environment in healthy infertile women.

2019

Abstract Research question There is some controversy regarding the impact of ovarian stimulation on immune cells in women undergoing IVF. The study's aim was to determine whether ovarian stimulation affected immune uterine cells in healthy women undergoing IVF. Design This prospective cohort study included 28 patients undergoing IVF and 47 healthy oocyte donors. Endometrial biopsies were taken in a natural cycle and after ovarian stimulation. All participants had a normal karyotype, pelvic ultrasound and cervical cytology results and thyroid-stimulating hormone concentration, as well as normal glucose and insulin concentrations and inherited and acquired thrombophilia test results. Screenin…

AdultNecrosisendocrine system diseasesPopulationStimulationEndometrial biopsies Immune cell populations Natural cycles Ovarian stimulation Peripheral blood natural killer cells Uterine natural killer cellsHuman leukocyte antigenAndrologyImmune systemOvulation InductionmedicineHumansEmbryo ImplantationProspective Studieseducationreproductive and urinary physiologyMenstrual Cycleeducation.field_of_studybusiness.industryUterusObstetrics and GynecologyFOXP3biochemical phenomena metabolism and nutritionfemale genital diseases and pregnancy complicationsKiller Cells NaturalReproductive MedicinebacteriaTumor necrosis factor alphaFemalemedicine.symptombusinessInfertility FemaleDevelopmental BiologyHormoneReproductive biomedicine online
researchProduct

Mild androgen phenotypes.

2006

Mild androgen phenotypes are found in 30-40% of patients referred to an endocrine clinic because of suspected hyperandrogenic syndrome. These disorders are characterized by clinical or biological signs of hyperandrogenism in women with normal ovulatory menstrual cycles. Three main mild androgen disorders may be distinguished: ovulatory polycystic ovarian syndrome (PCOS), idiopathic hyperandrogenism, and idiopathic hirsutism. Ovulatory PCOS includes ovulatory hyperandrogenic patients presenting with polycystic ovaries. Using ESHRE/ASRM criteria for diagnosis of PCOS, this disorder is now part of PCOS spectrum. While in vivo and in vitro studies have confirmed the similarities between the two…

AdultOvulationRiskmedicine.medical_specialtyHirsutismendocrine system diseasesmedicine.drug_classEndocrinology Diabetes and Metabolismmedia_common.quotation_subjectEndocrinologyInsulin resistanceInternal medicinemedicineEndocrine systemHumansOvulationhirsutismmedia_commonUltrasonographybusiness.industryHyperandrogenismOvarymedicine.diseaseAndrogenPhenotypePolycystic ovaryEndocrinologyPhenotypeCardiovascular DiseasesFemalebusinessHyperandrogenismPolycystic Ovary SyndromeBest practiceresearch. Clinical endocrinologymetabolism
researchProduct

Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome

2006

BACKGROUND Ovarian hyperstimulation syndrome (OHSS) is a life-threatening condition associated with ovarian stimulation. Its pathophysiology is unknown and its treatment continues to be empirical. Early (E)- and late (L)-OHSS occur in women at risk, though not in all cases. Vascular endothelial growth factor (VEGF) is related to increased vascular permeability in OHSS. We analysed the dynamics of the VEGF system in E- and L-OHSS. METHODS A prospective cohort of women undergoing IVF-ICSI treatment were divided into groups. E-OHSS: Nonpregnant patients classified as women not at risk (group 1) (n = 11) and patients at risk who did not (group 2) (n = 18) and did (group 3) (n = 8) develop sever…

AdultOvulationVascular Endothelial Growth Factor Amedicine.medical_specialtyTime Factorsmedia_common.quotation_subjectOvarian hyperstimulation syndromeVascular permeabilityOvaryFertilization in VitroBiologyCohort StudiesOvarian Hyperstimulation Syndromechemistry.chemical_compoundInternal medicineBlood plasmamedicineHumansalpha-MacroglobulinsSperm Injections IntracytoplasmicProspective cohort studyOvulationmedia_commonVascular Endothelial Growth Factor Receptor-1OvaryRehabilitationObstetrics and Gynecologymedicine.diseaseVascular endothelial growth factorEndocrinologymedicine.anatomical_structureReproductive MedicinechemistryOocytesFemaleSoluble fms-like tyrosine kinase-1Human Reproduction
researchProduct